Antigen Binding Articles & Analysis
61 articles found
These studies aim to identify whether antibodies or T cells generated against a particular antigen react with similar proteins found in different tissues, which can lead to unintended effects and complications. ...
They work by binding to foreign molecules, known as antigens, which can be proteins, polysaccharides, or other substances found on pathogens or abnormal cells. By binding to these antigens, antibodies can neutralize pathogens directly or mark them for destruction by other immune cells. ...
This specificity is achieved by linking a radioactive isotope to a monoclonal antibody or small molecule that targets specific cancer antigens. When administered, the RDCs selectively bind to the cancer cells, allowing for localized delivery of radiation. ...
Single-domain antibodies consist of a single polypeptide chain that retains the ability to bind specifically to antigens. Unlike traditional antibodies, which are composed of heavy and light chains, these smaller fragments are typically around 15 kDa in size. ...
These interactions are measured in real time, providing crucial insights into binding strength (affinity), association and dissociation rates (kinetics), and binding specificity. ...
This modification not only aids in their stability but also enhances their ability to recognize and bind to antigens effectively. Moreover, conjugated proteins are pivotal in biotechnology and pharmaceutical development. ...
Lectins are a type of protein that can recognize and bind to glycosyl structures. They usually have high specificity and affinity and can bind to specific glycosyl structures.Characteristic: It has high specificity and sensitivity, can be used to detect different types of glycosylation modifications, but some lectins may have binding ability to ...
For example, their molecular weight, volume and polarity are much higher than those of small molecule drugs, which make the pharmacokinetic properties of mAbs different. The specific binding between the mAb and the target can also greatly affect the elimination of the mAb drug. ...
Immunoassays Immunoassays are analytical techniques based on the specific binding between antibodies and antigens, enabling the quantitative analysis of anthocyanins in complex matrices. ...
In biomedical research, antibodies are a powerful tool used in the detection and quantification of target antigens. However, a comprehensive understanding of the antibody requires knowledge of its amino acid sequence, which can be achieved through antibody sequencing.Antibody sequencing is a nucleic acid sequencing process that determines the nucleotide sequence of the gene ...
They have the advantages of small size, high stability, and good penetration, and therefore have a wide range of application prospects in the fields of clinical treatment, diagnostic reagent development, etc.Characteristics of NanobodiesThe size of nanobodies usually ranges between 10-15kDa, which is only 1/10 of the size of regular antibodies. Their unique ...
Their monoclonal antibodies, linkers, linker-cytotoxin molecules, and newly introduced antigenic epitopes may all have immunogenicity. This makes the immune response induced by ADC drugs more complex. ...
In the environment of cancer, antigens may be specific to tumor cells and are known as tumor-specific antigens (TSAs) or tumor-associated antigens (TAAs). Antibodies, also known as immunoglobulins, are proteins produced by B-cells, a type of white blood cell. They recognize and bind to specific antigens, ...
Binding activity refers to the ability of an antibody to bind to its specific antigen. Here are some commonly used methods for evaluating the binding activity of antibody drugs:1. Enzyme-Linked Immunosorbent Assay (ELISA)ELISA is a common method that can quantify the binding ability of antibodies to ...
The T cell antigen receptor (TCR) is a characteristic marker of T cells, playing a crucial role in the immune system. ...
They can trigger an immune response in the human body by recognizing and binding to specific antigens, thereby combating pathogens. However, to develop monoclonal antibodies with high specificity and affinity, sequencing of the antibody's variable region is required. Sequencing the variable region of a monoclonal antibody refers to decoding the genetic ...
This epitope can be a unique area in the target antigen with specificity, allowing the antibody to accurately recognize and bind to it; or it can be those areas with cross-reactivity, allowing the antibody to interact with other proteins with similar sequences.Determine the Type of ExperimentThe types of experiments suitable for antibodies are often related to ...
At present, peptide drugs have shown broad application prospects in the treatment of tumors, hepatitis, diabetes, and AIDS.Antibody-Based TherapyAntibodies are proteins produced by the immune system that can bind to specific markers on cells or tissues. In cancer treatment, monoclonal antibodies (mAbs) can directly kill cancer cells, prevent the development of tumor blood ...
Mapping Epitopes and Paratopes Through antibody sequencing, we can determine epitopes (binding sites of antigens) and paratopes (binding sites of antibodies), reveal information that helps to draw epitope maps, guide antibody design, and paratope variations, which can enhance the specificity of antibody drugs. ...
Surface Plasmon Resonance (SPR)(1) Principle: It monitors the change in affinity of the antibody binding to a specific antigen to evaluate the effect of temperature on its functionality.(2) Application: It analyzes the functional stability of the antibody under different temperature conditions.4. ...